Prosecution Insights
Prosecution Insights
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 2 (67%) |
| Double-patenting + other | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHASE, CAROL ANN | 1 | 44.1% | +84.3% |
| WU, JULIE ZHEN QIN | 1 | 61.6% | +52.1% |
| NICKOL, GARY B | 1 | 45.3% | +28.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18312629 | ANTI-LAG-3 ANTIBODIES | WU, JULIE ZHEN QIN | 70d |
| 18570846 | TRIPLE COMBINATION THERAPY | CHASE, CAROL ANN | — |
| 17607828 | ANTI-LAG-3 BINDING MOLECULES | NICKOL, GARY B | — |
| Art Unit | Apps |
|---|---|
| 1643 | 1 |
| 1600 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18570846 | TRIPLE COMBINATION THERAPY | CHASE, CAROL ANN | — | §102§103§112DP | Non-Final OA | — | Pending | Dec 15, 2023 |
| 18312629 | ANTI-LAG-3 ANTIBODIES | WU, JULIE ZHEN QIN | 1643 | §112 | Non-Final OA | 70d | Pending | May 05, 2023 |
| 17607828 | ANTI-LAG-3 BINDING MOLECULES | NICKOL, GARY B | 1600 | §112 | Final Rejection | — | Pending | Oct 29, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial